Boston Collaborative for TMD Research

波士顿颞下颌关节紊乱病协作组织（BCTMD）由预先存在的， 目前在马萨诸塞州总医院内运行的相互关联的组件 (MGH)，哈佛牙科医学院（HSDM）和塔夫茨大学牙科学院 医学（TUSDM）。BCTMD协作包括一个强大的临床实践-口面疼痛 (OFP)和颞下颌关节（TMJ）手术，一项研究合作， 已经建立了几个以证据为基础的地方登记处，一个大型的TMJ滑膜数据库， 关节活组织检查，再生医学实验室专注于细胞和分子TMJ 研究，社区推广计划和培训计划的学生，研究员和 执业临床医生。BCTMD的目标是了解TMJ患者的需求， TMD中的牙科学校课程，影响获得护理的医疗保健服务差距， 进一步的基础和应用研究，以提高我们对颞下颌关节疾病的认识，并确保 TMD服务，无论是诊断还是治疗，都是适合每个患者的，并且已经得到证明 安全、准确、有效。BCTMD打算通过以下方式实现这些目标： 一个由TMD IMPACT利益相关者组成的国家框架，以阐明这些障碍， 登记研究，以便更好地了解我们的患者和疾病过程，目标治疗 通过基础和临床研究的战略，加强基于证据的结果的翻译， 临床护理，最后，使用这个国家TMD IMPACT框架来培训下一代 研究人员和临床医生。实现这些主要目标的合作需要 基础设施，临床医生，研究人员，教育工作者以及资源和BCTMD团队是 完全有能力实现这些目标。TMD IMPACT研究将是一项为期5年的研究。我们 第一年的目标是1。为了通过科学会议在全国范围内建立合作， 中央执行委员会，并确定研究的优先事项。2.将这些发现提交给 国家会议和出版物3.规划基础设施， 以证据为基础的国家患者登记系统，用于实现数据共享、协调 TMD IMPACT 4内的协调和互操作性。加强教育和CE 与以前确定的合作伙伴合作。未来四年将用于实施 这些全国性的登记处，开发用于加强临床和基础科学研究的工具， 使用这些登记册，开发TMD培训课程，增加社区外展， 以及患者倡导团体的参与。

The Boston Collaborative for Temporomandibular Disorders (BCTMD) consists of preexisting, interrelated components which currently function within the Massachusetts General Hospital (MGH), Harvard School of Dental Medicine (HSDM), and Tufts University School of Dental Medicine (TUSDM). The BCTMD collaborative consist of a robust clinical practice - Orofacial Pain (OFP) and Temporomandibular Joint (TMJ) surgery, a research collaborative where the group has developed several evidence-based local registries, a large data bank of TMJ synovial and joint biopsies, a regenerative medicine laboratory focused on cellular and molecular TMJ research, community outreach programs, and training programs students, research fellows and practicing clinicians. The goal of the BCTMD is to understand TMJ patient needs, the gaps in dental school curricula in TMD, gaps in healthcare delivery affecting access to care, the need for further basic and applied research to advance our knowledge of TMJ disease, and to ensure that TMD services, both diagnostic and treatment, are the right ones for each patient, and are proven to be safe, accurate and effective. The BCTMD intends to achieve these goals by working within a national framework of TMD IMPACT stakeholders to elucidate these barriers, develop national registries for a better understanding of our patients and disease processes, target treatment strategies through basic and clinical research, enhance translation of evidence-based findings to clinical care, and lastly, use this national TMD IMPACT framework to train the future generation of researchers and clinicians. Implementation of these main goals of the collaborative requires infrastructure, a team of clinicians, researchers, educators as well as resources and BCTMD is perfectly positioned to meet these goals. The TMD IMPACT study will be a 5-year study. Our goals for Year 1 will be 1. To build collaborations nationally through scientific meetings, form a central Executive Committee and establish priorities for research. 2. Present these findings at national meetings and generate publications 3. Planning infrastructure for development of evidence based national patient registries for implementing data sharing, coordination, harmonization and interoperability within the TMD IMPACT 4. Fortify the education and CE programs with previously identified collaborators. The next four years will be used in implementing these nationwide registries, developing tools for enhancing clinical and basic science research using these registries, developing curriculum for TMD training, increasing community outreach, and participation of patient advocacy groups.